CENTRAL NERVOUS SYSTEM NEOPLASM
Clinical trials for CENTRAL NERVOUS SYSTEM NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new CENTRAL NERVOUS SYSTEM NEOPLASM trials appear
Sign up with your email to follow new studies for CENTRAL NERVOUS SYSTEM NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope pill tested for kids with tough cancers
Disease control OngoingThis study is testing whether a pill called cabozantinib can help control rare cancers that have come back or stopped responding to other treatments in children and young adults. It includes patients with sarcomas, Wilms tumor, and other rare tumors. The drug aims to slow or stop…
Matched conditions: CENTRAL NERVOUS SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Targeted drug trial offers hope for kids with rare, Hard-to-Treat cancers
Disease control OngoingThis study is testing a targeted drug called larotrectinib in children and young adults (up to age 30) with specific types of cancer. The cancers must have a rare genetic change called a TRK fusion. The goal is to see if the drug can shrink tumors or control leukemia before other…
Matched conditions: CENTRAL NERVOUS SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC